Pages that link to "Q54267695"

The following pages link to Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus. (Q54267695):

Displaying 39 items.

• Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens (Q28546863) (← links)
• Increased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulin (Q33880228) (← links)
• Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms (Q35076815) (← links)
• Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity (Q35677483) (← links)
• Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections (Q35783692) (← links)
• Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens (Q35943844) (← links)
• Panton-Valentine leucocidin expression by Staphylococcus aureus exposed to common antibiotics (Q35949711) (← links)
• Effect of subinhibitory concentrations of tigecycline and ciprofloxacin on the expression of biofilm-associated genes and biofilm structure of Staphylococcus epidermidis (Q36365533) (← links)
• Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens. (Q36565579) (← links)
• Staphylococcal Enterotoxin O Exhibits Cell Cycle Modulating Activity (Q36799350) (← links)
• Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin (Q37287867) (← links)
• Delta Hemolysin and Phenol-Soluble Modulins, but Not Alpha Hemolysin or Panton-Valentine Leukocidin, Induce Mast Cell Activation. (Q37492021) (← links)
• Decrease of Staphylococcus aureus Virulence by Helcococcus kunzii in a Caenorhabditis elegans Model (Q37703063) (← links)
• Microbiological effects of sublethal levels of antibiotics. (Q38214805) (← links)
• The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus (Q38671478) (← links)
• Community-associated Staphylococcus aureus pneumonia among Greek children: epidemiology, molecular characteristics, treatment, and outcome (Q38824116) (← links)
• Inflammatory properties of antibiotic-treated bacteria (Q38941353) (← links)
• Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics (Q39022323) (← links)
• Staphylococcus aureus-Associated Musculoskeletal Infections (Q39092499) (← links)
• The Effect of Ferula assa-foetida L and Carum copticum Hydroalcoholic Extract on the Expression Levels of Staphylococcus aureus Genes Involved in Quorum Sensing (Q39109923) (← links)
• Diagnosis and management of Panton-Valentine leukocidin toxin associated Staphylococcus aureus infection: an update (Q40092261) (← links)
• Vancomycin modifies the expression of the agr system in multidrug-resistant Staphylococcus aureus clinical isolates. (Q40267325) (← links)
• Effects of Tedizolid Phosphate on Survival Outcomes and Suppression of Production of Staphylococcal Toxins in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia. (Q40352805) (← links)
• Tigecycline induction of phenol-soluble modulins by invasive methicillin-resistant Staphylococcus aureus strains. (Q42573064) (← links)
• Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages (Q45248748) (← links)
• Alterations of growth rate and gene expression levels of UPEC by antibiotics at sub-MIC. (Q48256161) (← links)
• Necrotising pneumonia following influenza due to PVL-negative Staphylococcus aureus in a 64-year-old woman. (Q50078786) (← links)
• Spa type distribution in MRSA and MSSA bacteremias and association of spa clonal complexes with the clinical characteristics of bacteremia (Q50079526) (← links)
• Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution. (Q51245149) (← links)
• Sub-inhibitory concentrations of oxacillin modify the expression of agr locus in Staphylococcus aureus clinical strains belonging to different clonal complexes. (Q52319948) (← links)
• Sub-Inhibitory Concentrations of Mupirocin Strongly Inhibit Alpha-Toxin Production in High-Level Mupirocin-Resistant MRSA by Down-Regulating agr, saeRS, and sarA. (Q55274140) (← links)
• Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains (Q57807303) (← links)
• Inhibition of Rho Activity Increases Expression of SaeRS-Dependent Virulence Factor Genes in Staphylococcus aureus, Showing a Link between Transcription Termination, Antibiotic Action, and Virulence (Q58725933) (← links)
• Daptomycin Resistant Clinical Strain With Novel Non-synonymous Mutations in the and Genes: A New Insight Into Daptomycin Resistance (Q59136449) (← links)
• Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children with Influenza-Related Critical Illness (Q59359084) (← links)
• Subinhibitory Concentrations of Fusidic Acid May Reduce the Virulence of S. aureus by Down-Regulating sarA and saeRS to Reduce Biofilm Formation and α-Toxin Expression (Q89965177) (← links)
• Antibiotic-Resistant Staphylococcus aureus Does Not Develop Resistance to Vanillic Acid and 2-Hydroxycinnamic Acid after Continuous Exposure in Vitro (Q90404429) (← links)
• Anti-staphylococcus Antibiotics Interfere With the Transcription of Leucocidin ED Gene in Staphylococcus aureus Strain Newman (Q90479456) (← links)
• CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial (Q92727222) (← links)